Plamen Kozlovski

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli et al. · JACC Heart Failure · 2017 · 160 citations · Full text

Metabolic Syndrome, Heart Failure, Cardiovascular Disease +9

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Steven E. Nissen, Kathy Wolski, Leslie Cho et al. · Open Heart · 2022 · 114 citations · Full text

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Wolfgang Kothny, James E. Foley, Plamen Kozlovski et al. · Diabetes Obesity and Metabolism · 2012 · 99 citations

PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

H.‐J. Lüddeke, Séamus Sreenan, Stefan Aczél et al. · Diabetes Obesity and Metabolism · 2006 · 86 citations

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study

Anne Dornhorst, Hans-Joachim Lüddeke, Séamus Sreenan et al. · International Journal of Clinical Practice · 2008 · 71 citations